
Infectious Diseases. Transplant and Oncology ID. @MDAndersonNews @UABHeersink @OchsnerHealth @ut_infectious
Houston, TX
Joined February 2019
- Tweets31
- Following113
- Followers77
- Likes69
Guy Handley retweeted
The joy of medicine, helping many patients and practicing Infectious Diseases @UTMDAnderson in #Houston. Today, with representation from USA, Japan, Azerbaijan, Peru, Ecuador, Venezuela, and Libya. #IDtwitter @apiinfectologia @ESCMID @IDSAInfo
Guy Handley retweeted
Non-tuberculous mycobacterial infections at a National Cancer Institute-Designated Comprehensive Cancer Center in Florida
✅ Just Accepted
🔗 bit.ly/4wL0FbN
Guy Handley retweeted
Out now, everything you need to know, that is known and not known, about herpesviruses after CAR T and BsAb, in our review with @Emily_Siegrist and @ChemalyRoy in @VirusesMDPI
@MDAndersonNews @OUCollegeofMed
mdpi.com/1999-4915/17/1/133
Guy Handley retweeted
Interested in Transplant and immunocompromised patients? Take a look at our program mdanderson.org/education-tra…
Guy Handley retweeted
A third year fellowship position in Transplant and Oncology Infectious Diseases is open at UT MD Anderson. Cutting edge cancer care, SCT, and CAR-T @MDAndersonNews and SOT @TXMedCenter. Enjoy working with @ut_infectious, @BCMIDFellowship and @MethodistHosp. DM @POkhuysen
Guy Handley retweeted
Moving forward with Hepatitis C elimination strategies @HarrysTorres01 @chiayuchiuID @AASLDtweets @MDAndersonNews
Guy Handley retweeted
Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark your calendars for May 11-14, 2025, for the 5th symposium on infections in immunocompromised individuals. Travel stipends available! bit.ly/4hgyLwS
Guy Handley retweeted
Check out our editorial to the @CMIJournal special theme issue State of the art reviews on infections in immunocompromised hosts, edited by @ChemalyRoy
@cskevaki @esgrev_escmid #TxID
clinicalmicrobiologyandinfec…
Guy Handley retweeted
Congratulations to J. Martin Rodriguez @uabmedicine on winning the Chatrchai Watanakunakorn award in recognition of outstanding achievement in the clinical practice of infectious diseases. Felicidades Martín!
Guy Handley retweeted
So incredibly proud of my mentor, colleague, and friend @jonathanhandMD for his dedication to this project and his advocacy for this patient population! 👏🥂💗 #TransplantID #HOPE @OchsnerHealth
Guy Handley retweeted
Great discussion with @ASP_MirandaS @davidvanduin @jonathanhandMD on short vs long antibiotic duration in immunocompromised hosts
Guy Handley retweeted
What is the trend of mortality among #PLWH with reproductive potential in Florida? Presented by Dr Rybolt, our chief ID fellow at #idweek #IDWeek2024
Guy Handley retweeted
Come learn about non-tuberculosis mycobacterial infections at our NCI-designated Comprehensive Cancer Center @MoffittNews at IDWeek2024 poster 798! #idweek #IDWeek2024 @apc_md @handleyg4
Guy Handley retweeted
Outcomes of Haploidentical Stem Cell Transplant Recipients with HHV-6B Reactivation
✅ Just Accepted
🔗 bit.ly/47V0QG4
Guy Handley retweeted
【Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections】Curr Opin Infect Dis, Oct 5 2024
👉Congrats, Erika @ErikaKampouri @fredhutch @unil🎉
👉Comprehensive review on the epidemiology of viral infections and critical approaches to prevention and management strategies following CAR-T-cell therapies!
journals.lww.com/co-infectio…
#TxID @JoshuaHillMD
Guy Handley retweeted
Happy to share our latest paper out - A review of recent advances and challenges with herpesviruses in HCT in @CMIJournal, with the great @Emily_Siegrist, and the best mentor @ChemalyRoy! Check it out!
#TxID #ChemalyTeam
clinicalmicrobiologyandinfec…
Guy Handley retweeted
Just published our experience using ceftaroline for invasive Staph infections with CNS or ocular involvement in @jac_amr, largest case series to date, work led by the amazing @Emily_Siegrist, check it out! @OUHealth @OU_Libraries
academic.oup.com/jacamr/arti…




























